PR NEWSWIRE

immediapress comunicato stampa

Tagworks Pharmaceuticals Announces CTA Authorization and Initiation of Phase 0/1 Clinical Trial for TGW211, a Radiopharmaceutical for the Treatment of HER2+ Tumors

NIJMEGEN, Netherlands and BOSTON, Oct. 15, 2025 /PRNewswire/ -- Tagworks Pharmaceuticals BV ("Tagworks"), a clinical-stage precision oncology company using its proprietary Click-to-Release treatment platform to develop a new standard of care for patients suffering from solid tumors, today announced t...

immediapress comunicato stampa

ICANN84 in Dublin: A Pivotal Moment for the Future of the Internet

DUBLIN, Oct. 15, 2025 /PRNewswire/ -- The Internet Corporation for Assigned Names and Numbers (ICANN) will hold its 84th Public Meeting, the Annual General Meeting (AGM), from 25–30 October 2025 at the Convention Centre Dublin in Dublin, Ireland. The event, hosted by the Internet Neutral Exchange Ass...

immediapress comunicato stampa

CATACARB® WINS CARBON REMOVER AWARD AT CARBON CAPTURE CANADA 2025

EDMONTON, AB, Oct. 15, 2025 /PRNewswire/ -- CATACARB is proud to announce it has been awarded the Carbon Remover Award at Carbon Capture Canada (Canada's National Carbon Capture and Storage Event) held in Edmonton. The Carbon Remover Award recognizes groundbreaking technologies and processes that adv...



SEGUICI SUI SOCIAL



threads whatsapp linkedin twitter youtube facebook instagram
ora in
Prima pagina
articoli
in Evidenza